Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.

Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE.

AIDS. 2007 Aug 20;21(13):1739-45.

PMID:
17690572
2.

Hepatitis C virus infection is associated with insulin resistance among older adults with or at risk of HIV infection.

Howard AA, Lo Y, Floris-Moore M, Klein RS, Fleischer N, Schoenbaum EE.

AIDS. 2007 Mar 12;21(5):633-41.

3.

Factors associated with seronegative chronic hepatitis C virus infection in HIV infection.

Chamie G, Bonacini M, Bangsberg DR, Stapleton JT, Hall C, Overton ET, Scherzer R, Tien PC.

Clin Infect Dis. 2007 Feb 15;44(4):577-83. Epub 2007 Jan 10.

4.

Diagnosis and classification of diabetes mellitus.

American Diabetes Association.

Diabetes Care. 2007 Jan;30 Suppl 1:S42-7. No abstract available.

PMID:
17192378
5.
6.

Abnormal glucose metabolism among older men with or at risk of HIV infection.

Howard AA, Floris-Moore M, Lo Y, Arnsten JH, Fleischer N, Klein RS.

HIV Med. 2006 Sep;7(6):389-96.

7.

Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.

Al-Harthi L, Voris J, Du W, Wright D, Nowicki M, Frederick T, Landay A, Kovacs A.

J Infect Dis. 2006 May 1;193(9):1202-10. Epub 2006 Mar 17.

8.

Insulin resistance in the HIV-infected population: the potential role of mitochondrial dysfunction.

Shikuma CM, Day LJ, Gerschenson M.

Curr Drug Targets Infect Disord. 2005 Sep;5(3):255-62. Review.

PMID:
16181144
9.

The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange S, Barranday Y, Holman S, Weber K, Young MA.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1013-9. Review. No abstract available.

10.

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.

Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, Chmiel JS, Visscher BR, Margolick JB, Dobs AS.

AIDS. 2005 Sep 2;19(13):1375-83.

PMID:
16103768
11.

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.

Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS.

Arch Intern Med. 2005 May 23;165(10):1179-84. Erratum in: Arch Intern Med. 2005 Nov 28;165(21):2541.

PMID:
15911733
12.

Disorders of glucose metabolism among HIV-infected women.

Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischer N, Lo Y, Schoenbaum EE.

Clin Infect Dis. 2005 May 15;40(10):1492-9. Epub 2005 Apr 11.

13.

The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.

Noor MA, Parker RA, O'Mara E, Grasela DM, Currie A, Hodder SL, Fiedorek FT, Haas DW.

AIDS. 2004 Nov 5;18(16):2137-44.

PMID:
15577646
14.

Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.

Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, Taniguchi E, Kumemura H, Hanada S, Maeyama M, Baba S, Koga H, Kumashiro R, Ueno T, Ogata H, Yoshimura A, Sata M.

Am J Pathol. 2004 Nov;165(5):1499-508.

15.

The metabolic effects of lopinavir/ritonavir in HIV-negative men.

Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz JM, Aweeka FT, Mulligan K, Schambelan M, Grunfeld C.

AIDS. 2004 Mar 5;18(4):641-9.

16.

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S, Moriya K, Koike K.

Gastroenterology. 2004 Mar;126(3):840-8.

PMID:
14988838
17.

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes.

Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N.

Hepatology. 2003 Dec;38(6):1384-92.

PMID:
14647049
18.

Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.

Cole SR, Hernán MA, Robins JM, Anastos K, Chmiel J, Detels R, Ervin C, Feldman J, Greenblatt R, Kingsley L, Lai S, Young M, Cohen M, Muñoz A.

Am J Epidemiol. 2003 Oct 1;158(7):687-94.

19.

Morphine induces desensitization of insulin receptor signaling.

Li Y, Eitan S, Wu J, Evans CJ, Kieffer B, Sun X, Polakiewicz RD.

Mol Cell Biol. 2003 Sep;23(17):6255-66.

20.

The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons.

Mehta SH, Moore RD, Thomas DL, Chaisson RE, Sulkowski MS.

J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):577-84.

PMID:
12902801
Items per page

Supplemental Content

Write to the Help Desk